RCMU
PRCT icon

Rokos Capital Management (UK)’s Procept Biorobotics PRCT Stock Holding History

Rokos Capital Management (UK)’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-20,000
Closed -$778K – 100
2021
Q3 		$778K Buy
+20,000
New +$768K 0.02% 82

Other funds holding PRCT

CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Rokos Capital Management (UK)'s PRCT Position: Q4 2021 in Review

Rokos Capital Management (UK) sold out of Procept Biorobotics (PRCT) in Q4 2021, closing a stake of 20,000 shares — an estimated $778K sold.

Rokos Capital Management (UK) first reported a position in PRCT in Q3 2021 and held it in 1 quarter. The position peaked at $778K in Q3 2021. 60 funds tracked by Wall St. Rank hold PRCT as of Q4 2021.

  • Rokos Capital Management (UK) reported no remaining Procept Biorobotics position as of Q4 2021 after selling out during the quarter.
  • Rokos Capital Management (UK) sold 20,000 Procept Biorobotics shares in Q4 2021, an estimated $778K.
  • Rokos Capital Management (UK) first reported a position in Procept Biorobotics in Q3 2021 and held it in 1 quarter.
  • Rokos Capital Management (UK)'s Procept Biorobotics position peaked at $778K in Q3 2021.
  • 60 funds tracked by Wall St. Rank held Procept Biorobotics as of Q4 2021.

Based on Rokos Capital Management (UK)'s 13F filing for Q4 2021, filed 14 Feb 2022.